• Inhibited breast cancer cell progression by influencing the matrix metalloproteinase, cyclooxygenase-2, nuclear transcription factor-κB, activator protein-1, phosphoinositide 3-kinase/Akt (PI3K/Akt) and extracellular signal-regulated kinase. This evidence concerns the gene PTGS2 and breast cancer.